You have 9 free searches left this month | for more free features.

Giant cell

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Giant Cell Arteritis Trial in Dijon (drug, other, biological, procedure)

Not yet recruiting
  • Giant Cell Arteritis
  • Tocilizumab treatment
  • +3 more
  • Dijon, France
    Chu Dijon Bourgogne
Sep 7, 2023

Diabetes Mellitus in Giant Cell Arthritis and Polymyalgia

Recruiting
  • Giant Cell Arteritis
  • +2 more
    • Aalborg, Nordjylland, Denmark
      Aalborg University Hospital
    Aug 21, 2023

    Vessel Wall Enhancement in Giant Cell Arteritis

    Recruiting
    • Giant Cell Arteritis
    • Magnetic Resonance Imaging (MRI)
    • Philadelphia, Pennsylvania
      3400 Civic Center Blvd
    May 9, 2023

    Patients With Horton's Disease (Giant Cell Arteritis) (EvHortim)

    Not yet recruiting
    • Giant Cell Arteritis
    • Injected cerebral MRI angiography and ultrasound of the superior aortic trunks, temporal and axillary arteries
    • (no location specified)
    Aug 22, 2023

    Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath Trial (Pimicotinib(ABSK021),

    Not yet recruiting
    • Tenosynovial Giant Cell Tumor
    • +2 more
    • (no location specified)
    Apr 5, 2023

    Giant Cell Arteritis, Polymyalgia Rheumatica Trial (Secukinumab)

    Not yet recruiting
    • Giant Cell Arteritis
    • Polymyalgia Rheumatica
    • (no location specified)
    Nov 8, 2023

    Giant Cell Tumor of Bone Trial in Beijing (Narlumosbart, Denosumab)

    Not yet recruiting
    • Giant Cell Tumor of Bone
    • Beijing, Beijing, China
      Beijing Ji Shui Tan Hospital
    Apr 16, 2023

    Applanation Tonometry in the Diagnosis of Giant Cell Arteritis

    Not yet recruiting
    • Giant Cell Arteritis
    • Applanation tonometry
    • Montreal, Quebec, Canada
      Vasculitis Clinic, Hopital du Sacre-Coeur de Montreal
    Jan 26, 2023

    Spatial Resolution of Several Contrast-enhanced 3D T1-WI

    Not yet recruiting
    • Giant Cell Arteritis
    • 3D T1 MRI sequences injected with fat saturation and black blood
    • (no location specified)
    May 9, 2023

    Giant Cell Tumor of Bone Trial in Hangzhou, Lishui, Ningbo (4mg ZOL loaded gentamicin PMMA, gentamicin PMMA)

    Not yet recruiting
    • Giant Cell Tumor of Bone
    • 4mg ZOL loaded gentamicin PMMA
    • gentamicin PMMA
    • Hangzhou, Zhejiang, China
    • +2 more
    Feb 1, 2023

    Giant Cell Tumor of Bone Trial (Dietary Supplement: Calcium/Vitamin D)

    Active, not recruiting
    • Giant Cell Tumor of Bone
    • Dietary Supplement: Calcium/Vitamin D
    • Beijing, China
      Beijing Ji Shui Tan Hospital
    Oct 13, 2022

    Vasculitis, Diagnoses Disease Trial in Würzburg (CXCR4-PET)

    Recruiting
    • Vasculitis
    • Diagnoses Disease
    • CXCR4-PET
    • Würzburg, Bayern, Germany
      Departement of Internal Medicine II, Rheumatology/Clinical Immun
    Dec 4, 2022

    Optic Nerve Sheath Ultrasound in Giant Cell Arteritis

    Not yet recruiting
    • Giant Cell Arteritis
    • +2 more
    • Optic nerve ultrasound
    • Joliette, Quebec, Canada
    • +3 more
    Feb 18, 2023

    Oral Care of Patients Treated With Anti-RANK-ligand Antibodies

    Recruiting
    • Giant Cell Tumors
      • Strasbourg, France
        Service de Médecine et Chirurgie Bucco-Dentaires - CHU de Strasb
      Sep 12, 2022

      Giant Cell Arteritis Trial in Bonn (Methotrexate, Sodium chloride)

      Recruiting
      • Giant Cell Arteritis
      • Bonn, Germany
        Medical Clinic and Polyclinic III Internal medicine Oncology, He
      Dec 16, 2022

      TGCT Trial in Washington, Baltimore (Emactuzumab, Placebo)

      Active, not recruiting
      • TGCT
      • Washington, District of Columbia
      • +1 more
      Sep 23, 2022

      Temporal Artery Biopsy Following Dynamic Full-field Optical

      Recruiting
      • Giant Cell Arteritis
      • Tomography, Optical Coherence
      • Dynamic full-field optical coherence tomography analysis of temporal artery biopsy
      • Chalon sur Saône, Saône-et-Loire, France
        Centre Hospitalier William Morey - Chalon sur Saône
      Jan 26, 2023

      Giant Cell Arteritis Trial in Nice

      Completed
      • Giant Cell Arteritis
        • Nice, Alpes-Maritimes, France
          Hospital of the Archet
        Jul 20, 2022

        Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, TGCT Trial in Germany, Poland, Ukraine (AMB-05X)

        Active, not recruiting
        • Tenosynovial Giant Cell Tumor
        • +3 more
        • AMB-05X
        • Berlin, Germany
        • +4 more
        Oct 5, 2022

        Giant Cell Arteritis Trial (Secukinumab 300 mg, s.c., Placebo to match Secukinumab, s.c.)

        Recruiting
        • Giant Cell Arteritis
        • Secukinumab 300 mg, s.c.
        • Placebo to match Secukinumab, s.c.
        • Berlin, Germany
        • +2 more
        Oct 12, 2022

        Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis Trial in Worldwide (AMB-05X)

        Active, not recruiting
        • Tenosynovial Giant Cell Tumor
        • Pigmented Villonodular Synovitis
        • AMB-05X
        • Columbus, Ohio
        • +5 more
        Oct 5, 2022

        PET Imaging of Giant Cell and Takayasu Arteritis

        Active, not recruiting
        • Giant Cell Arteritis
        • Takayasu Arteritis
        • PET-MRI
        • Cambridge, Cambridgeshire, United Kingdom
        • +1 more
        Jul 31, 2022

        Tenosynovial Giant Cell Tumor Trial in Japan (Pexidartinib)

        Recruiting
        • Tenosynovial Giant Cell Tumor
        • Aichi, Japan
        • +5 more
        Jun 29, 2022

        Patients of Unresectable Giant Cell Tumor of Bone

        Completed
        • Giant Cell Tumor of Bone
        • Beijing, Beijing, China
        • +2 more
        May 30, 2022

        Giant Cell Arteritis - Optimization of Diagnostics

        Recruiting
        • Giant Cell Arteritis
        • Giant cell arteritis
        • Copenhagen, Denmark
          Rigshospitalet
        Feb 10, 2022